l General Information |
Product Name | Labetalol HCl |
General description | Labetalol HCl is a dual antagonist for both selective alpha1-adrenergic and nive beta-adrenergic receptors, used in the treatment of high blood pressure. |
Synonym | 2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide; hydrochloride |
Purity | ≥98.0%(HPLC) | CAS Number | 32780-64-6 |
Formula | C19H25ClN2O3 | Molecular Weight | 364.87 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White to off-white Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Water | ~5mg/ml |
l Biological Information |
Biochem/Physiol
Actions | Labetalol Hydrochloride is the hydrochloride form of labetalol, a third generation selective alpha-1-adrenergic antagonist and non-selective beta-adrenergic antagonist with vasodilatory and antihypertensive properties. Labetalol competitively binds to alpha-1-adrenergic receptors in vascular smooth muscle, thereby inhibiting the adrenergic stimulation of endothelial cell function and vasoconstriction in peripheral blood vessels. This agent also binds to beta-receptors in the bronchial and vascular smooth muscle, resulting in a decrease in adrenergic stimulation. The result is a decrease in resting and exercise heart rates, cardiac output, and in both systolic and diastolic blood pressure, thereby resulting in vasodilation, and negative chronotropic and inotropic cardiac effects. |
Application | 1.Antihypertensive Agents 2.Adrenergic alpha-1 Receptor Antagonists 3.Adrenergic beta-Antagonists 4.Sympathomimetics |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |